| Authors: |
Nassar FJ; Epigenomics and Mechanisms Branch, International Agency for Research on Cancer, Lyon, France., Cahais V; Epigenomics and Mechanisms Branch, International Agency for Research on Cancer, Lyon, France., McKay JA; Department of Applied Sciences, Northumbria University, Newcastle upon Tyne, UK., Strathdee G; Biosciences Institute, Newcastle University Centre for Cancer, Newcastle University, Newcastle upon Tyne, UK., Lee YS; Department of Cancer Biomedical Science, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, 10408, Korea., Spitz N; Epigenomics and Mechanisms Branch, International Agency for Research on Cancer, Lyon, France., Nickels E; Center for Genetic Epidemiology, University of Southern California, Los Angeles, United States of America.; Cancer and Blood Disease Institute, Children's Hospital Los Angeles, Los Angeles, USA., Nordlund J; Department of Medical Sciences, Molecular Precision Medicine and Science for Life Laboratory, Uppsala University, Uppsala, Sweden., Saffery R; Murdoch Children's Research Institute and Department of Paediatrics, University of Melbourne, Melbourne, Australia., Dwyer T; Clinical Sciences Theme, Heart Group, Murdoch Children's Research Institute, Melbourne, Australia.; Nuffield Department of Women's & Reproductive Health, University of Oxford, Oxford, UK.; Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Australia., Magnus P; Centre for Fertility and Health, Norwegian Institute of Public Health, Oslo, Norway., Munthe-Kaas MC; Department of Pediatric Oncology and Hematology, Oslo University Hospital, Oslo, Norway., Herceg Z; Epigenomics and Mechanisms Branch, International Agency for Research on Cancer, Lyon, France., Wiemels JL; Center for Genetic Epidemiology, University of Southern California, Los Angeles, United States of America., Ghantous A; Epigenomics and Mechanisms Branch, International Agency for Research on Cancer, Lyon, France. GhantousA@iarc.who.int. |
